Global Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: G9DFC3290B77EN
QYResearch

Abstracts

Spinal and Bulbar Muscular Atrophy Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Spinal and Bulbar Muscular Atrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

• AbbVie
• Pfizer
• GlaxoSmithKline
• Johnson & Johnson
• Century Pharmaceuticals
• Astellas Pharma
• Sanofi
• Boehringer Ingelheim International

Market segment by Type, the product can be split into

• 5?-Reductase Inhibitors
• Gonadotropin-releasing Hormone Agonists

Market segment by Application, split into

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Spinal and Bulbar Muscular Atrophy Treatment Revenue
1.4 Market by Type
  1.4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 5?-Reductase Inhibitors
  1.4.3 Gonadotropin-releasing Hormone Agonists
1.5 Market by Application
  1.5.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Orthopedic Clinics
  1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Perspective (2015-2026)
2.2 Global Spinal and Bulbar Muscular Atrophy Treatment Growth Trends by Regions
  2.2.1 Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Spinal and Bulbar Muscular Atrophy Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Spinal and Bulbar Muscular Atrophy Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Spinal and Bulbar Muscular Atrophy Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Market Size
  3.1.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue (2015-2020)
  3.1.2 Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio
  3.2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2019
3.3 Spinal and Bulbar Muscular Atrophy Treatment Key Players Head office and Area Served
3.4 Key Players Spinal and Bulbar Muscular Atrophy Treatment Product Solution and Service
3.5 Date of Enter into Spinal and Bulbar Muscular Atrophy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020)
5.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2015-2020)
6.2 Spinal and Bulbar Muscular Atrophy Treatment Key Players in North America (2019-2020)
6.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020)
6.4 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size (2015-2020)
7.2 Spinal and Bulbar Muscular Atrophy Treatment Key Players in Europe (2019-2020)
7.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020)
7.4 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Spinal and Bulbar Muscular Atrophy Treatment Market Size (2015-2020)
8.2 Spinal and Bulbar Muscular Atrophy Treatment Key Players in China (2019-2020)
8.3 China Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020)
8.4 China Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size (2015-2020)
9.2 Spinal and Bulbar Muscular Atrophy Treatment Key Players in Japan (2019-2020)
9.3 Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020)
9.4 Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size (2015-2020)
10.2 Spinal and Bulbar Muscular Atrophy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Spinal and Bulbar Muscular Atrophy Treatment Market Size (2015-2020)
11.2 Spinal and Bulbar Muscular Atrophy Treatment Key Players in India (2019-2020)
11.3 India Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020)
11.4 India Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2015-2020)
12.2 Spinal and Bulbar Muscular Atrophy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AbbVie
  13.1.1 AbbVie Company Details
  13.1.2 AbbVie Business Overview
  13.1.3 AbbVie Spinal and Bulbar Muscular Atrophy Treatment Introduction
  13.1.4 AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020))
  13.1.5 AbbVie Recent Development
13.2 Pfizer
  13.2.1 Pfizer Company Details
  13.2.2 Pfizer Business Overview
  13.2.3 Pfizer Spinal and Bulbar Muscular Atrophy Treatment Introduction
  13.2.4 Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020)
  13.2.5 Pfizer Recent Development
13.3 GlaxoSmithKline
  13.3.1 GlaxoSmithKline Company Details
  13.3.2 GlaxoSmithKline Business Overview
  13.3.3 GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Introduction
  13.3.4 GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020)
  13.3.5 GlaxoSmithKline Recent Development
13.4 Johnson & Johnson
  13.4.1 Johnson & Johnson Company Details
  13.4.2 Johnson & Johnson Business Overview
  13.4.3 Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Introduction
  13.4.4 Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020)
  13.4.5 Johnson & Johnson Recent Development
13.5 Century Pharmaceuticals
  13.5.1 Century Pharmaceuticals Company Details
  13.5.2 Century Pharmaceuticals Business Overview
  13.5.3 Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Introduction
  13.5.4 Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020)
  13.5.5 Century Pharmaceuticals Recent Development
13.6 Astellas Pharma
  13.6.1 Astellas Pharma Company Details
  13.6.2 Astellas Pharma Business Overview
  13.6.3 Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Introduction
  13.6.4 Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020)
  13.6.5 Astellas Pharma Recent Development
13.7 Sanofi
  13.7.1 Sanofi Company Details
  13.7.2 Sanofi Business Overview
  13.7.3 Sanofi Spinal and Bulbar Muscular Atrophy Treatment Introduction
  13.7.4 Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020)
  13.7.5 Sanofi Recent Development
13.8 Boehringer Ingelheim International
  13.8.1 Boehringer Ingelheim International Company Details
  13.8.2 Boehringer Ingelheim International Business Overview
  13.8.3 Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Introduction
  13.8.4 Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020)
  13.8.5 Boehringer Ingelheim International Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Spinal and Bulbar Muscular Atrophy Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Spinal and Bulbar Muscular Atrophy Treatment Revenue
Table 3. Ranking of Global Top Spinal and Bulbar Muscular Atrophy Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of 5?-Reductase Inhibitors
Table 6. Key Players of Gonadotropin-releasing Hormone Agonists
Table 7. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2015-2020)
Table 11. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Spinal and Bulbar Muscular Atrophy Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Spinal and Bulbar Muscular Atrophy Treatment Players
Table 18. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Players (2015-2020)
Table 20. Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal and Bulbar Muscular Atrophy Treatment as of 2019)
Table 21. Global Spinal and Bulbar Muscular Atrophy Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Spinal and Bulbar Muscular Atrophy Treatment Product Solution and Service
Table 24. Date of Enter into Spinal and Bulbar Muscular Atrophy Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Type (2015-2020)
Table 28. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2015-2020)
Table 30. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Spinal and Bulbar Muscular Atrophy Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Spinal and Bulbar Muscular Atrophy Treatment Market Share (2019-2020)
Table 34. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2015-2020)
Table 36. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Spinal and Bulbar Muscular Atrophy Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Spinal and Bulbar Muscular Atrophy Treatment Market Share (2019-2020)
Table 40. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2015-2020)
Table 42. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Spinal and Bulbar Muscular Atrophy Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Spinal and Bulbar Muscular Atrophy Treatment Market Share (2019-2020)
Table 46. China Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2015-2020)
Table 48. China Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Spinal and Bulbar Muscular Atrophy Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Spinal and Bulbar Muscular Atrophy Treatment Market Share (2019-2020)
Table 52. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2015-2020)
Table 54. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Spinal and Bulbar Muscular Atrophy Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Spinal and Bulbar Muscular Atrophy Treatment Market Share (2019-2020)
Table 58. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Spinal and Bulbar Muscular Atrophy Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Spinal and Bulbar Muscular Atrophy Treatment Market Share (2019-2020)
Table 64. India Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2015-2020)
Table 66. India Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Spinal and Bulbar Muscular Atrophy Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Spinal and Bulbar Muscular Atrophy Treatment Market Share (2019-2020)
Table 70. Central & South America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2015-2020)
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Product
Table 77. AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020) (Million US$)
Table 78. AbbVie Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Product
Table 87. GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Recent Development
Table 94. Century Pharmaceuticals Company Details
Table 95. Century Pharmaceuticals Business Overview
Table 96. Century Pharmaceuticals Product
Table 97. Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020) (Million US$)
Table 98. Century Pharmaceuticals Recent Development
Table 99. Astellas Pharma Company Details
Table 100. Astellas Pharma Business Overview
Table 101. Astellas Pharma Product
Table 102. Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020) (Million US$)
Table 103. Astellas Pharma Recent Development
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Product
Table 107. Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020) (Million US$)
Table 108. Sanofi Recent Development
Table 109. Boehringer Ingelheim International Business Overview
Table 110. Boehringer Ingelheim International Product
Table 111. Boehringer Ingelheim International Company Details
Table 112. Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2015-2020) (Million US$)
Table 113. Boehringer Ingelheim International Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type: 2020 VS 2026
Figure 2. 5?-Reductase Inhibitors Features
Figure 3. Gonadotropin-releasing Hormone Agonists Features
Figure 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Orthopedic Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Spinal and Bulbar Muscular Atrophy Treatment Report Years Considered
Figure 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Players in 2019
Figure 14. Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal and Bulbar Muscular Atrophy Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2019
Figure 16. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed